FROM bizjournals
Cary's Calvert Holdings, a privately held company whose subsidiaries focus on clinical services, is launching a new venture-capital fund - with a twist.
Calvert BioCapital plans to invest in early-stage biopharmaceutical compounds and technologies, the rights of which will be held by a separate entity called Calvert Development.
Another Calvert business, Calvert Laboratories, will develop the compounds through preclinical or phase I trials. Calvert Development will then sub-license the compounds, with investors sharing in the proceeds from the divestment.
Subscribe to:
Post Comments (Atom)
1 comment:
Good to see you brother..keep it up!!
Post a Comment